Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 May;83(5):522-6.
doi: 10.1111/j.1349-7006.1992.tb01959.x.

The number of platinum atoms binding to DNA, RNA and protein molecules of HeLa cells treated with cisplatin at its mean lethal concentration

M Akaboshi  1 , K Kawai, H Maki, K Akuta, Y Ujeno, T Miyahara
Affiliations

The number of platinum atoms binding to DNA, RNA and protein molecules of HeLa cells treated with cisplatin at its mean lethal concentration

M Akaboshi et al. Jpn J Cancer Res. 1992 May.

Abstract

HeLa S-3 cells were treated with 195mPt-radiolabeled cis-diamminedichloroplatinum(II) (CDDP) under various conditions, and the relationship between lethal effect and the number of Pt atoms binding to DNA, RNA and proteins was examined. The mean lethal concentrations for the cells treated with CDDP at 37 degrees C for 1, 2 and 3 h were 2.8, 2.0 and 1.1 microgram/ml, respectively. By using identically treated cells, the number of Pt atoms combined with DNA, RNA and protein molecules were determined after fractionation of the cells using the method of Schneider. In this way, the D0 values given as the drug concentration were substituted for the number of Pt atoms combined with each fraction, then the target volumes expressed as the reciprocals of D0 values were calculated for each fraction. The results provide strong support for the idea that DNA is the primary target for cell killing by CDDP, and the target volumes were 5.17 x 10(4), 5.71 x 10(4) and 1.03 x 10(5) nucleotides for 1, 2 and 3 h treated cells, respectively.

PubMed Disclaimer

References

    1. ) Zak , M. and Drobnik , J.Effect of cis‐diamminedichloroplatinum(II) on the post irradiation lethality in mice after irradiation with X‐rays . Strahlentherapie , 142 , 112 – 115 ( 1971. ). - PubMed
    1. ) Einhorn , I. H. and Donohue , J.cis‐Diamminedichloroplatinum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer . Ann. Intern. Med. , 87 , 293 – 298 ( 1977. ). - PubMed
    1. ) Young , R. C.Gynecologic malignancies . In “ Cancer Chemotherapy ,” ed. Pinedo H. , pp. 340 – 375 ( 1979. ). Excerpta Medica; , Amsterdam .
    1. ) Loehrer , P. J. and Abildgaarad , U.Cisplatin . Ann. Intern. Med. , 100 , 704 – 713 ( 1984. ). - PubMed
    1. ) Welling , L. A. , Anderson , T. and Kohn , K. W.DNA‐protein and DNA interstrand cross‐linking by cis‐ and trans‐platinum(II)diamminedichloride in L1210 mouse leukemia cells and its relation to cytotoxicity . Cancer Res. , 39 , 365 – 368 ( 1979. ). - PubMed

LinkOut - more resources